Starpharma Holdings Limited products

VivaGel® BV is available for sale under the brand names Betafem® BV Gel (UK), Betadine BVTM (Europe), BetadineTM BV Gel (Asia) and Fleurstat BVgel (Australia & New Zealand). VivaGel® has been developed for the treatment of BV and prevention of recurrent bacterial vaginosis (BV).  BV is caused by an imbalance of the normal vaginal bacterial microflora, with healthy bacteria (e.g. Lactobacillus species) being depleted and harmful bacteria (e.g. Gardnerella vaginalis) overly abundant. VivaGel® formulated as a mucoadhesive gel (VivaGel® BV) has been approved for marketing in the European Union as a 7-day therapy for treatment and prevention of BV including its symptoms.  VivaGel® BV has been shown to have efficacy for treatment of BV in a Phase 2 clinical study and was shown to achieve statistically significant cure of the signs and symptoms of BV at the end of treatment in two Phase 3 studies. 

Starpharma’s VivaGel® condom is the world’s first and only antiviral condom. The physical barrier of the condom provides primary protection against sexually transmitted infections (STIs). The condom is lubricated with VivaGel® lubricant.  VivaGel® (SPL7013, or astodrimer sodium) is an antiviral agent proven, in laboratory studies only, to inactivate HIV, herpes simplex virus (HSV) and human papillomavirus (HPV), which are viruses that cause STIs.

VivaGel® (SPL7013, or astodrimer sodium) is an innovative agent applied to a range of marketed women’s health and sexual wellness products. The safety and efficacy of VivaGel® has been successfully tested in several clinical studies.  VivaGel® is a proprietary dendrimer that is antiviral and blocks bacteria. When formulated as a mucoadhesive gel and delivered vaginally, VivaGel® has been shown to relieve the signs and symptoms of bacterial vaginosis (BV), and to reduce risk of recurrence of BV, in clinical studies. Further, VivaGel® has been shown, in laboratory studies, to have broad-spectrum and potent antiviral activity against a wide range of viruses, including HIV, herpes simplex, hepatitis B, HPV, Zika, adenovirus, RSV and SARS-CoV-2 (the coronavirus that causes COVID-19).